Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-28, Stock:ABT, The news for the past five days is as follows:
2019-03-21: NEWS1: Spruce Point: Dexcom Could Fall 45-60%.NEWS2: Big-data software firm Tresata's upcoming hackathon to tackle public health.NEWS3: Big-data software firm Tresata's upcoming hackathon to tackle public health.NEWS4: Edwards Lifesciences Presents Positive Partner 3 Trial Data.NEWS5: Edwards Lifesciences Presents Positive Partner 3 Trial Data.NEWS6: Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results.NEWS7: Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results.NEWS8: Notable ETF Outflow Detected - IWD, INTC, T, ABT.NEWS9: Notable ETF Outflow Detected - IWD, INTC, T, ABT.NEWS10: Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results.NEWS11: Edwards Lifesciences Presents Positive Partner 3 Trial Data.
2019-03-22: NEWS1: Varian (VAR) Scales New 52-Week High on Solid Prospects.NEWS2: Here's Why DexCom Shares Are Dropping Today.NEWS3: Here's Why DexCom Shares Are Dropping Today.NEWS4: Here&apos;s Why DexCom Shares Are Dropping Today.NEWS5: Baxter (BAX) Soars to 52-Week High, Time to Cash Out?.NEWS6: Baxter (BAX) Soars to 52-Week High, Time to Cash Out?.
2019-03-25: NEWS1: Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip.NEWS2: Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip.NEWS3: Abbott (ABT) Gains As Market Dips: What You Should Know.NEWS4: Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip.NEWS5: Abbott's New CE Mark to Boost Core Laboratory Diagnostics Arm.NEWS6: Abbott's New CE Mark to Boost Core Laboratory Diagnostics Arm.NEWS7: Abbott's New CE Mark to Boost Core Laboratory Diagnostics Arm.NEWS8: Quest Diagnostics Grows on New Pacts Amid Reimbursement Issue.NEWS9: 6 Excellent Dividend Growth Stocks to Buy Now.
2019-03-26: NEWS1: What Are Abbott Laboratories' Key Sources of Revenue?.NEWS2: What Are Abbott Laboratories' Key Sources of Revenue?.
2019-03-27: NEWS1: Were Hedge Funds Right About Selling Abbott Laboratories (ABT)?.

Answer: Rise